Biden’s Inaction Moves Health Care Fight To States
In Colorado and Washington state, lawmakers are grappling with how to create public health insurance alternatives in the face of industry opposition.
Health Care
Deep dives into the political corruption and corporate bureaucracy that keeps Americans sick while making executives rich.
“They Can’t Hold The Nursing Homes Responsible”
Across New York state, Cuomo’s nursing home liability shield has caused a legal chilling effect, reducing a deterrent to corporate wrongdoing.
Dems’ Gift To Health Insurance Predators
Democrats want to pay billions to put Americans on expensive corporate health insurance plans rather than expand Medicare or create a public option.
How Wall Street Kills Grandma
20,000 nursing home residents died from 2004 to 2016 because they lived in nursing homes run by private equity firms, according to updated data.
Cuomo-gate: A Nixonian Scandal Is Engulfing New York
Gov. Cuomo is threatening retribution against Dems demanding answers about underreported COVID deaths and his effort to help an industry group shield nursing home execs.
Republicans Fight Paid Sick Leave Protections Despite Raging Pandemic
Under the guise of helping businesses, the GOP is working to bar medical leave mandates one state at a time.
Drugmakers Want Vaccine Pricing Decisions Kept Secret
Pfizer and Johnson & Johnson are working to block votes on shareholder resolutions that would force them to disclose how government funding affects their drug prices.
States Are Ignoring New Data Showing How To Halt COVID Spread
New research shows stay-at-home orders and eviction bans are key — but Gov. Gavin Newsom is reopening California with a weak eviction moratorium.
Biden Lifts Health Care Plan From Insurance Lobbyists
The incoming president’s plan mimics an insurance industry letter, instead of pushing a promised public option or Democratic legislation to expand Medicare.
Drug Monopolies Must Have Their Big Tech Moment
If we want to curb the power of pharmaceutical companies and rising drug prices, let’s look at the patent system.